Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
80 participants
INTERVENTIONAL
2026-02-01
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The program will be able to effectively monitor daily step count. A health coach will receive more this detailed data and will guide weekly health coaching sessions designed to increase awareness of the physical activities completed and ignite inner motivation for healthy behaviors.
The proposed PR program is innovative and responds to an unmet need in chronic care for COPD patients in the context of COVID-19 pandemic and it mitigates the common accessibility barriers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Home Pulmonary Rehabilitation for COPD
NCT03480386
Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients
NCT02999685
Home-Based Health Management of COPD Patients
NCT02557178
Home-based Exercise Training for COPD Patients
NCT03461887
The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD
NCT02099799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Aim 1: To determine the feasibility of the proposed home-based PR program. We will additionally address adherence and appropriateness of the program.
* Aim 2: To determine improvements in quality of life and mental health of the proposed home-based PR determined.
* Aim 3: To evaluate if the average number of daily step counts increase after the home-based PR program
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home based exercise
Home based exercise with health coaching
Home based exercise
Exercise at home and behavioural change to increase daily exercise
Usual care
Usual care, waiting list
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home based exercise
Exercise at home and behavioural change to increase daily exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FEV1 \<80% or less (forced expiratory volume in one second) as documented by pulmonary function.
* Medical diagnosis of COPD, GOLD classification B,D, and C based on symptoms and history of exacerbations.
* The patients must be able to access a smart-phone or computer tablet with internet service.
Exclusion Criteria
* Patients with a high likelihood of being lost to follow-up or contact (patients with active chemical dependency), are planning to move, are not living in the healthcare area.
* Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).
40 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marian Papp
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marian Papp, PhD
Role: PRINCIPAL_INVESTIGATOR
Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Karolinska Institutet
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-01151:DNR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.